| Company/Division name | AbbVie |
| Parent company | AbbVie |
| Type of work | Manufacturing |
| Reshoring category: | Reshoring |
| Total number of jobs (added or to be added): | 200 |
| Year reshoring announced: | 2026 |
| Year reshoring implemented or to be implemented: | 2035 |
| Capital investment ($): | 175 |
| City reshored to: | Tempe |
| State(s) reshored to: | AZ |
| If relevant, work nearshored to: | - |
| Industry(ies): | Chemicals |
| Product(s) reshored | pharma and devices |
| What domestic positive factors made reshoring more attractive? | Eco-system synergies, Infrastructure, Manufacturing/engineering joint innovation (R&D), Proximity to customers/market, Under-utilized capacity |
